About this trial
Optic neuritis (ON) represents around 30% of clinical presentation of clinically isolated syndrome (CIS). Asymptomatic optic nerve involvement is very frequent in all stage of multiple sclerosis (MS) disease including the CIS. However, optic nerve is still not part of MS diagnosis criteria. The main objective of our regional and multicenter study is to evaluate the prognostic value of optic nerve involvement at the earliest clinical stage of MS (=CIS) for the diagnosis of clinically definite MS (2nd clinical relapse) and the delay until the 2nd relapse.
Eligibility criteria
Qualifiers
Patients between 18 and 55 years old
Occurrence of CIS ≤ 6 months
With two T2 hypersignals on brain/spinal cord MRI suggestive of MS or with oligoclonal bands
Giving their written informed consent
Disqualifiers
Pathological conditions that may skew the optic nerve MRI and/or retinal OCT (diabetes mellitus, glaucoma, retinopathy, ametropia >6 dioptria)
Past history of MS relapses
Extensive myelitis (>3 vertebral bodies)
Bilateral optic neuritis without T2 lesions suggestive of MS
Trial design
Treatments tested in this trial
- Optic nerve MRI sequence
Treatment groups
Sponsors and collaborators
University Hospital, Lille
Lead sponsor
Région Nord-Pas de Calais, France
Collaborator
Amiens University Hospital
Collaborator
Boulogne sur Mer Hospital Center
Collaborator
Centre Hospitalier VALENCIENNES
Collaborator
Centre Hospitalier de Roubaix
Collaborator
Centre Hospitalier de Lens
Collaborator